Turkish Cognitive Self-Efficacy Questionnaire in Parkinson's Disease for adults with PD
Official title: Validity and Reliability of the Turkish Version of the Cognitive Self-Efficacy Questionnaire in Individuals With Parkinson's Disease
Run by Acibadem University · NCT07488377 · Data updated 2026-11-12
This study tests whether the Turkish version of the Cognitive Self-Efficacy Questionnaire is reliable and valid for people with Parkinson's disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years to 85 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Acibadem University Academic / other |
| Locations | 1 site (Istanbul, Turkey) |
| Status | Recruiting |
| Started | April 1, 2026 |
| Main results expected | January 1, 2027 |
| Study ends | April 1, 2027 |
| Registry record updated | July 15, 2026 |
| Trial ID | NCT07488377 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 40–85 with Parkinson's disease, Hoehn and Yahr 1–3, MMSE ≥24, able to consent and complete assessments, attending Istanbul Cerrahpaşa Neurology/Movement Disorders Clinic.
✕Probably not a fit
Patients with advanced dementia, major depression or psychotic disorders, severe sensory impairments, or inability to complete assessments may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study assesses the reliability and validity of the Turkish Cognitive Self-Efficacy Questionnaire in individuals with Parkinson's disease. Participants are adults aged 40–85 with PD in Hoehn and Yahr stages 1–3, who can complete assessments and consent. The study uses the Turkish questionnaire as the sole instrument to measure cognitive self-efficacy and evaluate its psychometric properties. Participants are recruited from the Movement Disorders Outpatient Clinic at Istanbul Cerrahpaşa and must meet MMSE and other inclusion criteria. No intervention beyond questionnaire completion is described.
Why it matters
Potential benefit: If successful, the Turkish questionnaire could provide a validated tool for measuring cognitive self-efficacy in Turkish-speaking PD patients.
How similar studies have gone: Previous work in other languages supports the use of this type of instrument, but validation in Turkish for PD is being established by this study.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical diagnosis of Parkinson's disease * Hoehn and Yahr stage 1-3 * Age 40 to 85 years * Mini-Mental State Examination (MMSE) score ≥24 * Able to communicate and complete study assessments * Attending the Movement Disorders Outpatient Clinic, Department of Neurology, Istanbul Cerrahpaşa Faculty of Medicine Hospital * Able and willing to provide written informed consent Exclusion Criteria: * Major depressive disorder or psychotic disorder * Advanced dementia * Severe visual impairment that may interfere with study assessments * Severe hearing impairment that may interfere with study assessments * Inability to cooperate with the physiotherapist * Inability to complete the study assessments
Where it's running
-
Acibadem University
Istanbul, Turkey, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Nuray ALACA
- Email: nuray.alaca@acibadem.edu.tr
- Phone: 05324251290
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.